1.	Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase IV, Phase III Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631
2.	RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CRAD001KDE37, EudraCT 2010-022273-34, 2010-022273-34, NCT01317615
3.	Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors Phase: Phase IV Type: Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: UKM08_0057, 2009-018072-33, NCT01424839
4.	MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I Phase: Phase IV Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P0334, NCT01501487
5.	A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225 AM1) (KMEC) Phase: Phase IV Type: Supportive care Status: Active Age: 21 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 0869-225, MK-0869-225, NCT01636947
6.	Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MITO-16 - MANGO-OV2, 2012-003043-29, NCT01706120
7.	Phase II/III Randomized Study of Carboplatin and Ifosfamide With or Without Whole Body Hyperthermia in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Extraovarian Peritoneal Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: LMU-DOLPHIN-1, EU-20220, NCT00045461
8.	Phase II/III Randomized Pilot Study of the Timing of Surgery and Chemotherapy in Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III, Phase II Type: Treatment Status: Active Age: Adult Sponsor: Other Protocol IDs: RCOG-MRC-CHORUS, EU-20350, ISRCTN74802813, NCT00075712
9.	A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: Haema CBF SCLC UK/AS 01, NCT00168896
10.	Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: OV21, CAN-NCIC-OV21, UCL08/0379, GEICO-0902, SWOG OV.21, CDR0000655241, NCT00993655
11.	Cisplatin and Radiation Therapy With or Without Gemcitabine Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced Nasopharyngeal Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000657121, SINGAPORE-NCC0901, NCC0901, NCT00997906
12.	Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 59 Sponsor: Other Protocol IDs: M09TNM, 2009-015238-31, NCT01057069
13.	Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TG4010.14/TIME, 8559, NCT01383148
14.	Neoadjuvant Chemotherapy vs. Chemoradiation for Resectable Esophageal Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CDHA 147937-7, NCT01404156
15.	Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GBG 66, 2011-000553-23, NCT01426880
16.	Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial Phase: Phase III, Phase II Type: Treatment Status: Active Age: 20 and over Sponsor: Other Protocol IDs: GOTIC-001/JGOG3019, UMIN000003670, NCT01506856
17.	Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy Phase: Phase III, Phase II Type: Treatment Status: Active Age: 20 and over Sponsor: Other Protocol IDs: D7913L00077, NCT01579630
18.	Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 20 at diagnosis Sponsor: Other Protocol IDs: CDR0000069191, SIOP-EUROPE-HR-NBL-1, ESIOP, EU-20148, NCT00030719
19.	Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor Phase: Phase III Type: Treatment Status: Active Age: 18 and under Sponsor: Other Protocol IDs: CDR0000257531, SIOP-WT-2001, SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138
20.	Phase III Randomized Study of Gemcitabine in Combination With Cisplatin Versus Carboplatin in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CRUK-BTOG2-LU3005, EU-20510, NCT00112710
21.	A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 11718, UVACC-ONYX-11718, UVACC-HIC-11860, EUDRACT-2005-0000941-12, BAYER-UVACC-ONYX-11718, NCT00111007
22.	Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 119 of 2003, NCT00193739
23.	Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: TROG 05.01, NCT00193895
24.	Random Trial for Elderly Patients With NSCLC Phase: Phase III Type: Treatment Status: Active Age: 65 and over Sponsor: Other Protocol IDs: INJE05-06, NCT00265694
25.	Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 3 Sponsor: NCI, Other Protocol IDs: CDR0000483683, COG-ACNS0334, ACNS0334, NCT00336024